This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rambus Loses Another Legal Battle

Updated from 4:05 p.m. ET

Rambus (RMBS - Get Report) is now 0-2 in its court battle with Germany's Infineon Technologies (IFX).

Just days after a judge tossed out the remaining pieces of Rambus' key patent-infringement suit against Infineon, a jury in the U.S. District Court in Richmond, Va., said Wednesday that Rambus was liable for fraud and ordered it to pay punitive damages of $3.5 million in its battle with the German chipmaker. Infineon had charged that Rambus deliberately concealed that it was applying for patents for synchronous dynamic random access memory chips while the Joint Electron Device Engineering Council, a trade group that worked on developing a standard for memory, was working on a common standards for the chips, according to Reuters.

Rambus said it would immediately appeal the fraud verdict. "We are obviously disappointed in today's verdict and will immediately appeal,'' Geoff Tate, Rambus CEO, said in a statement. "The innovations at issue are Rambus inventions, and the evidence presented at trial made it clear that Infineon knew all along that they were Rambus inventions."

Rambus, in its broad efforts to get other chipmakers to pay for what it contends are its chip designs, had sued Infineon charging patent infringement. But a U.S. District Court for the Eastern District of Virginia judge dismissed the last of those claims last week, punishing Rambus' stock.

Rambus' stock closed Wednesday down 90 cents, or 6.6%, to $12.80.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
RMBS $14.40 0.00%
AAPL $129.62 -2.20%
FB $79.34 -1.50%
GOOG $532.32 -1.44%
TSLA $247.46 -0.11%

Markets

DOW 18,041.54 -190.48 -1.04%
S&P 500 2,104.20 -21.86 -1.03%
NASDAQ 5,032.7510 -56.6110 -1.11%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs